1. Home
  2. QNCX vs BW Comparison

QNCX vs BW Comparison

Compare QNCX & BW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$0.10

Market Cap

167.0M

Sector

Health Care

ML Signal

HOLD

Logo Babcock & Wilcox Enterprises Inc.

BW

Babcock & Wilcox Enterprises Inc.

HOLD

Current Price

$10.56

Market Cap

919.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
QNCX
BW
Founded
2012
1867
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Building Products
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
167.0M
919.9M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
QNCX
BW
Price
$0.10
$10.56
Analyst Decision
Hold
Buy
Analyst Count
3
3
Target Price
$10.00
$7.00
AVG Volume (30 Days)
33.4M
3.8M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$16.59
Revenue Next Year
N/A
$14.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.09
$0.22
52 Week High
$4.55
$14.90

Technical Indicators

Market Signals
Indicator
QNCX
BW
Relative Strength Index (RSI) 27.86 49.03
Support Level $0.09 $8.03
Resistance Level $0.98 $11.57
Average True Range (ATR) 0.01 1.24
MACD 0.09 0.18
Stochastic Oscillator 18.57 37.55

Price Performance

Historical Comparison
QNCX
BW

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

About BW Babcock & Wilcox Enterprises Inc.

Babcock & Wilcox Enterprises Inc is a power generation equipment supplier and servicing company that operates in three segments: B&W Renewable, B&W Environmental, and B&W Thermal. B&W Thermal, focuses on steam generation products and solutions for plants in the power generation, oil, and gas, and industrial sectors, generates the majority of the company's revenue. B&W Renewable focuses on sustainable power and heat generation while B&W Environmental focuses on emissions control. The company's customer base spans the industrial, electrical utility, and municipal industries located predominantly in the United States, Canada, Denmark, the United Kingdom, and other regions. Business in the U.S. contributes the vast majority of its revenue.

Share on Social Networks: